| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
24,431 |
23,676 |
$1.15M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,361 |
23,058 |
$747K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,554 |
10,359 |
$573K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,369 |
9,906 |
$282K |
| 94760 |
|
59,871 |
53,810 |
$241K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,711 |
7,829 |
$155K |
| 99215 |
Prolong outpt/office vis |
4,080 |
3,886 |
$152K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13,014 |
10,750 |
$122K |
| 99051 |
|
28,158 |
26,476 |
$68K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,941 |
2,253 |
$53K |
| 99205 |
Prolong outpt/office vis |
678 |
666 |
$53K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,348 |
4,213 |
$40K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,148 |
1,044 |
$33K |
| 99000 |
|
9,873 |
9,554 |
$21K |
| H0033 |
Oral medication administration, direct observation |
2,526 |
2,494 |
$19K |
| 81002 |
|
11,501 |
11,093 |
$15K |
| 81025 |
|
6,098 |
5,874 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,722 |
2,676 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
587 |
487 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
539 |
533 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,070 |
1,011 |
$6K |
| 93000 |
|
389 |
385 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,336 |
1,302 |
$3K |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
741 |
721 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
895 |
871 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
2,692 |
2,619 |
$1K |
| 99173 |
|
577 |
559 |
$1K |
| 82962 |
|
715 |
693 |
$930.16 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
230 |
223 |
$812.71 |
| 86308 |
|
143 |
141 |
$388.93 |
| 73630 |
|
27 |
26 |
$376.18 |
| 85018 |
|
206 |
202 |
$281.76 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
496 |
482 |
$233.48 |
| 73610 |
|
18 |
17 |
$200.37 |
| 69209 |
|
12 |
12 |
$108.71 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
164 |
162 |
$28.49 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
95 |
86 |
$6.02 |
| 36416 |
|
12 |
12 |
$0.00 |